News

Natural Capsules Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited on October 9, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, with Cameo Corporate Services Limited acting as the Registrar & Share Transfer Agent.

Natural Capsules Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for equity shares will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of financial results for the quarter ended September 30, 2026, with the board meeting date to be announced later.

Natural Capsules Limited convened its 1st Extraordinary General Meeting on Wednesday, September 9, 2026, via video conference, where shareholders approved a special resolution for the issuance of equity shares and warrants convertible into equity shares on a preferential basis. Mr. Tekkar Yashwanth Prabhu, Chairman, presided over the meeting, which was attended by 31 members constituting the requisite quorum, and Mr. Sunil L Mundra, Managing Director, addressed the meeting regarding the preferential issue. The results of the voting will be declared upon receipt of the Scrutinizer`s report and submitted to the stock exchanges separately.

Natural Capsules Limited announced the results of its 1st Extraordinary General Meeting held on Wednesday, September 9, 2026, disclosing that two special resolutions were passed with the requisite majority. The resolutions pertained to the issuance of equity shares and warrants convertible into equity shares on a preferential basis. The company, along with Deepak Sadhu, Practicing Company Secretary, conducted the e-voting process, which commenced on September 4, 2026, and concluded on September 8, 2026, with a final 15-minute window after the meeting.

Natural Capsules is undertaking a preferential allotment of 4,50,000 convertible warrants to Mr. Sunil Mundra, a promoter, to raise Rs 8.01 Crores, approximately $9.7 million USD. The funds will primarily be used to meet working capital requirements, with a potential reallocation to capital expansion initiatives if opportunities arise. Following the allotment and assuming full conversion of warrants, the promoter and promoter group’s shareholding will increase to 53.44%, while public shareholding will decrease to 46.56%. The allotment complies with Securities and Exchange Board of India (ICDR) Regulations, and the company has obtained a certificate confirming this compliance. The funds are expected to be utilized within 18 months from the allotment date, September 10, 2026.